H Orfeuvre Selected Research

H Orfeuvre Research Topics

5	Breast Neoplasms (Breast Cancer) 01/2016 - 12/2001
4	Ovarian Neoplasms (Ovarian Cancer) 02/2009 - 01/2004
3	Neoplasms (Cancer) 01/2016 - 05/2001
2	Vomiting 11/2007 - 12/2001
2	Nausea 11/2007 - 12/2001
1	Glucosephosphate Dehydrogenase Deficiency 07/2009
1	Infections 11/2007
1	Mucositis 11/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2001

3	taxaneIBA 01/2016 - 03/2004
3	PlatinumIBA 02/2009 - 02/2007
2	liposomal doxorubicin (Doxil)FDA Link 12/2009 - 02/2007
2	Carboplatin (JM8)FDA LinkGeneric 11/2007 - 02/2007
1	Bevacizumab (Avastin)FDA Link 01/2016
1	exemestane (Aromasin)FDA Link 01/2016
1	1-dodecylpyridoxal (PLD)IBA 12/2009
1	Docetaxel (Taxotere)FDA Link 12/2009
1	Pharmaceutical PreparationsIBA 07/2009
1	rasburicase (Elitek)FDA Link 07/2009
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2009
1	Gemcitabine FDA Link 02/2009
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2007
1	human ERBB2 proteinIBA 03/2007
1	Monoclonal AntibodiesIBA 03/2007
1	Trastuzumab (Herceptin)FDA Link 03/2007
1	Capecitabine (Xeloda)FDA Link 03/2004
1	AnthracyclinesIBA 03/2004
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	ParaffinIBA 01/2004
1	Biomarkers (Surrogate Marker)IBA 01/2004
1	AntiemeticsIBA 12/2001
1	Interferon-alpha (Interferon Alfa)IBA 05/2001
1	Interleukin-3 (Interleukin 3)IBA 05/2001

4	Drug Therapy (Chemotherapy) 01/2016 - 12/2001
2	Therapeutics 01/2016 - 12/2009